戈尔吉蛋白73促进肝细胞癌中的血管生成
Yiming Liu1,2,3, Xinyang Hu2,3, Sining Zhou4
1Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, Hangzhou City University School of Medicine, Hangzhou 310015, China.
Research (Washington, D.C.)
|July 18, 2024
概括
戈尔吉蛋白73 (GP73) 通过稳定缺氧诱导因子-1α (HIF-1α) 和激活Ras-MAPK信号,促进肝细胞癌 (HCC) 血管生成. 向GP73可能为HCC提供一种新的抗血管性疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 戈尔吉蛋白73 (GP73) 在肝细胞癌 (HCC) 中升高,并影响瘤微环境 (TME).
- 确切地说,GP73影响HCC TME的精确分子机制仍然不完全阐明.
研究的目的:
- 调查GP73在调节HCC瘤微环境中的血管生成中的作用.
- 为了确定受GP73在HCC中影响的分子相互作用和信号通路.
主要方法:
- 研究了GP73与prolyl氧酶-2 (PHD-2) 的相互作用及其对HCC细胞中缺氧诱导的因子-1α (HIF-1α) 氧化的影响.
- 分析了由人类静脉内皮细胞 (HUVECs) 内部化的外体GP73.
- 研究了GP73与HECTD1的相互作用及其对生长因子受体结合蛋白2 (GRB2) 稳定性及其对Ras-mitogen-activated protein kinase (MAPK) 途径激活的影响.
主要成果:
- GP73具有竞争性抑制PHD-2,减少HIF-1α氧化和增加血管内皮生长因子A (VEGFA) 在HCC细胞中的产生.
- 来自HCC细胞的外体GP73被HUVEC内部化,在那里它与HECTD1相互作用,稳定GRB2并激活Ras-MAPK通路.
- 升高的GP73增强了VEGFA的产生,并强化了内皮细胞中的线粒生成信号,促进了TME血管生成.
结论:
- 通过调节HIF-1α稳定性和激活内皮细胞信号传递,GP73在促进HCC血管生成方面发挥着至关重要的作用.
- 在HCC血管生成中GP73的功能突出显示了其作为抗血管性策略的治疗点的潜力.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Golgi Matrix Proteins
2.0K
Golgi matrix proteins are a group of highly dynamic proteins that maintain the stacked structure of Golgi. These proteins adapt to rapid morphological changes of the Golgi during the cell cycle. During cell division, mild proteolysis removes these connections resulting in Golgi unstacking. In The daughter cells, these proteins help reassemble the unstacked Golgi.
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...
2.0K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K
Coat Assembly and GTPases
3.5K
Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
3.5K
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
GPI Anchoring of Proteins in the ER Membrane
4.0K
GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
4.0K


